Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial

RM Pressler; GB Boylan; N Marlow; M Blennow; C Chiron; JH Cross; LS (Linda) de Vries; B Hallberg; L Hellstrom-Westas; V Jullien; V Livingstone; B Mangum; B Murphy; D Murray; G Pons; J Rennie; R.M.C. Swarte; MC Toet; S Vanhatalo; S Zohar

doi:10.1016/S1474-4422(14)70303-5

Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial

RM Pressler, GB Boylan, N Marlow, M Blennow, C Chiron, JH Cross, LS (Linda) de Vries, B Hallberg, L Hellstrom-Westas, V Jullien, V Livingstone, B Mangum, B Murphy, D Murray, G Pons, J Rennie, R.M.C. Swarte, MC Toet, S Vanhatalo, S Zohar

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

223 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	469-477
Number of pages	9
Journal	Lancet Neurology
Volume	14
Issue number	5
DOIs	https://doi.org/10.1016/S1474-4422(14)70303-5
Publication status	Published - 2015

Research programs

EMC MM-03-54-04-A

Access to Document

10.1016/S1474-4422(14)70303-5

Cite this

Pressler, RM., Boylan, GB., Marlow, N., Blennow, M., Chiron, C., Cross, JH., de Vries, LS., Hallberg, B., Hellstrom-Westas, L., Jullien, V., Livingstone, V., Mangum, B., Murphy, B., Murray, D., Pons, G., Rennie, J., Swarte, R. M. C., Toet, MC., Vanhatalo, S., & Zohar, S. (2015). Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial. Lancet Neurology, 14(5), 469-477. https://doi.org/10.1016/S1474-4422(14)70303-5

@article{bfe98b4c119144f991e2641f3dd27bf3,

title = "Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial",

author = "RM Pressler and GB Boylan and N Marlow and M Blennow and C Chiron and JH Cross and {de Vries}, {LS (Linda)} and B Hallberg and L Hellstrom-Westas and V Jullien and V Livingstone and B Mangum and B Murphy and D Murray and G Pons and J Rennie and R.M.C. Swarte and MC Toet and S Vanhatalo and S Zohar",

year = "2015",

doi = "10.1016/S1474-4422(14)70303-5",

language = "Undefined/Unknown",

volume = "14",

pages = "469--477",

journal = "Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Ltd.",

number = "5",

}

Pressler, RM, Boylan, GB, Marlow, N, Blennow, M, Chiron, C, Cross, JH, de Vries, LS, Hallberg, B, Hellstrom-Westas, L, Jullien, V, Livingstone, V, Mangum, B, Murphy, B, Murray, D, Pons, G, Rennie, J, Swarte, RMC, Toet, MC, Vanhatalo, S & Zohar, S 2015, 'Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial', Lancet Neurology, vol. 14, no. 5, pp. 469-477. https://doi.org/10.1016/S1474-4422(14)70303-5

TY - JOUR

T1 - Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial

AU - Pressler, RM

AU - Boylan, GB

AU - Marlow, N

AU - Blennow, M

AU - Chiron, C

AU - Cross, JH

AU - de Vries, LS (Linda)

AU - Hallberg, B

AU - Hellstrom-Westas, L

AU - Jullien, V

AU - Livingstone, V

AU - Mangum, B

AU - Murphy, B

AU - Murray, D

AU - Pons, G

AU - Rennie, J

AU - Swarte, R.M.C.

AU - Toet, MC

AU - Vanhatalo, S

AU - Zohar, S

PY - 2015

Y1 - 2015

U2 - 10.1016/S1474-4422(14)70303-5

DO - 10.1016/S1474-4422(14)70303-5

M3 - Article

SN - 1474-4422

VL - 14

SP - 469

EP - 477

JO - Lancet Neurology

JF - Lancet Neurology

IS - 5

ER -